Revolutionary Initiative for Autism Screening in Morocco
On March 16, 2026, Perth, Australia, witnessed a significant milestone in healthcare technology as BlinkLab's Dx1 platform was officially selected by the Kingdom of Morocco for a groundbreaking, government-funded autism screening initiative. This program, which aims to screen approximately 600,000 children born annually, is the first of its kind globally and represents a monumental step towards early autism detection facilitated through smartphone technology. The initiative, ordered under the auspices of His Majesty King Mohammed VI, was formalized on August 29, 2025, through a multi-ministerial national framework convention, underlining the Moroccan government's strong commitment to addressing autism on a national scale.
Significantly, the implementation of this program comes at no cost to BlinkLab, as all expenses are covered by the Moroccan Government and the Mohammed V Foundation for Solidarity, allowing BlinkLab to retain all data rights. The initial screening centers are set to open this April, with plans for a phased expansion across approximately 3,000 public primary healthcare centers, marking a substantial increase in accessibility to autism screening services for Moroccan families.
Innovative Technology for Accurate Autism Diagnosis
BlinkLab's Dx1 platform utilizes a standard smartphone camera alongside advanced AI-driven computer vision techniques to capture objective, reflex-based neurometric biomarkers. This innovative approach measures various physical responses from children, including facial reflexes, startle responses, and vocal reactions during a brief 15-minute session where they watch age-appropriate videos. Unlike traditional autism assessment methods that rely on subjective observations, BlinkLab’s technology provides objective, reproducible neurometric data that enhances diagnostic accuracy. In a significant peer-reviewed study involving 536 children, published in Autism Research in January 2026, the Dx1 platform exhibited a remarkable 91% sensitivity in identifying autism-related sensorimotor profiles across diverse populations and age groups.
The program not only aims for early diagnosis but is also designed to address the pressing need for timely interventions. Autism currently affects an estimated 1 in 36 children worldwide, with over 400,000 individuals living with autism in Morocco alone. Given the substantial delays faced by families in securing formal assessments—averaging three years in the United States—this initiative is pivotal in creating early intervention opportunities. By commencing screenings at just 18 months old, the Moroccan government seeks to establish a critical early intervention window that could significantly improve outcomes for children diagnosed with autism.
Dr. Henk-Jan Boele, Managing Director and CEO of BlinkLab, emphasized that the collaboration with the Mohammed VI National Center for the Disabled (CNMH) has been vital in demonstrating the effectiveness of their technology. This partnership has underscored the platform's operational ease and high diagnostic accuracy, which ultimately influenced the government’s decision to implement the Dx1 platform nationwide. As Morocco sets a precedent for large-scale, smartphone-based autism screening, the implications for Australia and other global regions are profound, highlighting the urgent need for accessible and efficient diagnostic solutions in the realm of public health.
As reported by newshub.medianet.com.au.
